tiprankstipranks
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market
1672
Ascletis Pharma, Inc.
RESEARCH TOOLSreports

Ascletis Pharma, Inc. (1672) Stock News & Sentiment

8 Followers
Ascletis Advances Fixed-Dose Oral Obesity Pill Toward U.S. FDA IND in 2026
Premium
Company Announcements
Ascletis Advances Fixed-Dose Oral Obesity Pill Toward U.S. FDA IND in 2026
6d ago
1672
Ascletis Deepens R&D Push in Obesity Drugs as 2025 Loss Widens
Premium
Company Announcements
Ascletis Deepens R&D Push in Obesity Drugs as 2025 Loss Widens
12d ago
1672
Ascletis Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Ascletis Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
26d ago
1672
Ascletis Advances Oral Amylin Agonist ASC39 Toward U.S. IND for Obesity
Premium
Company Announcements
Ascletis Advances Oral Amylin Agonist ASC39 Toward U.S. IND for Obesity
27d ago
1672
Ascletis Posts Positive U.S. Phase II Data for Monthly GLP-1 Obesity Drug ASC30
Premium
Company Announcements
Ascletis Posts Positive U.S. Phase II Data for Monthly GLP-1 Obesity Drug ASC30
1M ago
1672
Ascletis Advances Oral Amylin Obesity Drug ASC36 Toward U.S. Clinical Trials
Premium
Company Announcements
Ascletis Advances Oral Amylin Obesity Drug ASC36 Toward U.S. Clinical Trials
2M ago
1672
Ascletis Raises HK$835 Million to Fund Global Phase III Obesity Drug Trials
Premium
Company Announcements
Ascletis Raises HK$835 Million to Fund Global Phase III Obesity Drug Trials
2M ago
1672
More HK:1672 News >

1672 News on the Web

Ascletis Advances Fixed-Dose Oral Obesity Pill Toward U.S. FDA IND in 2026
TipRanks News
Bullish
Orient Securities Keeps Their Buy Rating on Ascletis Pharma, Inc. (1672)
TipRanks News
Bullish
Ascletis Pharma, Inc. (1672) Gets a Hold from Goldman Sachs
TipRanks News
Neutral
Ascletis Deepens R&D Push in Obesity Drugs as 2025 Loss Widens
TipRanks News
Neutral
Ascletis Pharma Sets March 31 Board Meeting to Approve 2025 Results and Consider Dividend
TipRanks News
Neutral
Ascletis Advances Oral Amylin Agonist ASC39 Toward U.S. IND for Obesity
TipRanks News
Bullish
Ascletis Posts Positive U.S. Phase II Data for Monthly GLP-1 Obesity Drug ASC30
TipRanks News
Bullish
Ascletis Advances Oral Amylin Obesity Drug ASC36 Toward U.S. Clinical Trials
TipRanks News
Bullish

News Score - Last 7 Days

Positive
HK:1672
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1672’s Media Buzz Sentiment?
2 articles about HK:1672 were published this week. In an average week, 1.5 articles are published.
    What is HK:1672’s weekly average amount of articles?
    In an average week, 1.5 articles about HK:1672 are published.
      What is HK:1672’s News Sentiment?
      100% of articles about HK:1672 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week